Auto-injectable diazepam formulation for rapid treatment of uncontrolled seizures
Ended Project Grant Awarded Last action
- Award ID
- R44NS086229
- Recipient
-
Xeris Pharmaceuticals, Inc. UEI YAV5AK7VKJ31
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,051,241
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- Illinois, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$53,986 | |
| Amendment | $0 | |
| Amendment | $793,851 | |
| Amendment | $797,247 | |
| Original award | $514,129 |
Quick answers
Who received award R44NS086229?
R44NS086229 was awarded to Xeris Pharmaceuticals, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2015.
How much is award R44NS086229 worth?
$2,051,241 has been obligated on R44NS086229.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award